Acute Porphyria Drug Database

Monograph

D07AB01 - Clobetasone
Not porphyrinogenic
NP

Rationale
Several references stating non- porphyrinogenicity of glucocorticoids.
Chemical description
Moderately strong Glucocorticoid ointment and creme 0.05 % used in skin treatment. Systemic exposure in application on large areas of the body. Glucocorticoid: South African list: use. Kalman, Bonkovsky: believed to be safe. The Merck Manual: use. Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe. Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncan’s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939: safe.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes D07A / D07AB or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Clobavate · Clobetasone · Clobetasone 0.05% cream 50% in Aqueous cream · Coal tar / Clobetasone · Eumovate · Eumovate Eczema and Dermatitis
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙